Otsuka Pharmaceutical Development & Commercialization: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Neurology, Psychiatry, and Pain

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaNeurology, Psychiatry, and Pain
Active Phase II & III Studies16 active (9 recruiting now)
Total Tracked Studies (2018 to 2026)58 (33 with California sites)
Completed vs Early-Stopped Studies33 completed / 9 stopped (15.5% stop rate)
Median Closed Enrollment272 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure46.1% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Otsuka Pharmaceutical across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk